Retina Program

Wednesday

CME BREAKFAST SEMINAR

6:30 am – 7:30 am
Advancing Science in the Treatment of Diabetic Retinopathy: Where We’ve Been and Where We’re Going
Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

GENERAL SESSION

Diabetic Retinopathy and Retinal Vascular Disease

Moderator: Michael S. Ip, MD
7:31 am – 7:48 am
Fluorescein Angiography: Still Relevant? The Kaiser-permanente Experience
Robin A. Vora, MD
7:49 am – 8:06 am
Managing Central Serous
Andrew A. Moshfeghi, MD, MBA
8:07 am – 8:24 am
RVO Management (Steroids/Anti-VEGF)
Sophie J. Bakri, MD
8:25 am – 8:41 am
Score 2 Update
Michael S. Ip, MD
8:42 am – 8:59 am
Management of Diabetic Macular Edema: Where Are We in 2019?
Sophie J. Bakri, MD
9:00 am – 9:30 am
REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL
9:31 am – 9:48 am
PRP vs. anti-VEGF for Proliferative Diabetic Retinopathy. Which is the Best Management?
Michael S. Ip, MD
9:49 am – 10:05 am
Should We Treat Advanced Non-Proliferative Diabetic Retinopathy?
Michael S. Ip, MD
10:06 am – 10:29 am
So You Want to Sell Your Practice: An Introduction to Private Equity
Reginald J. Sanders, MD
10:30 am – 11:00 am
REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL
11:01 am – 11:59 am
Instructive Retinal Vascular Cases
Moderator: Michael S. Ip, MD
Panelists: Sophie J. Bakri, MD; R.V. Paul Chan, MD, MSc, FACS; Allen C. Ho, MD; Andrew A. Moshfeghi, MD, MBA; Reginald J. Sanders, MD

CME LUNCH SEMINAR

12:00 pm – 1:00 pm
Beyond the Burden: New Options and Regimens for the Treatment of Neovascular Age-related Macular Degeneration
Supported by Novartis Pharmaceuticals Corporation

WORKSHOPS**

2:00 pm – 4:00 pm
Practical Training in Equipment, Technology and Insurance
**Not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2019 or its accredited provider.

BANYAN TREE SESSION

4:15 pm – 5:15 pm
AMD, DME, RVO
Sophie J. Bakri, MD; Michael S. Ip, MD